Cue Biopharma, Inc. (CUE) Balance sheet

Market cap

$938.48M

P/E ratio

	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	-	44	75	64	52	49	22
Marketable securities, current	18	15	10	-	25	-	-
Total cash & short-term investments	-	59	85	64	76	49	22
Accounts receivable, net	-	754,898	1	3	57,252	2	1
Total current assets	41	61	88	68	77	51	25
Property, plant and equipment, net	3	2	2	2	1	1	0
Total non-current assets	5	11	12	15	14	10	7
Total assets	45	72	100	83	91	62	32
Accounts payable	2	882,666	2	3	3	4	3
Total current liabilities	6	12	16	13	12	17	14
Long-term debt, non-current	-	-	-	-	8	4	-
Total non-current liabilities	5	5	4	5	14	7	1
Total liabilities	11	17	21	18	26	24	15
Common stock and paid-in capital	20,697	26,562	30,351	32,202	43,000	0	0
Retained earnings	-71,801,161	-108,500,118	-153,285,039	-197,446,214	-250,456,596	-301	-342
Stockholders' equity	34	55	79	65	66	37	17
Total debt	-	-	-	-	8	4	-
Net debt	-	-	-	-	-68,254,102	-44	-
D/E ratio (%)	-	-	-	-	12.2	11.3	-